338 related articles for article (PubMed ID: 22513430)
1. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
2. The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up.
Bouvier AM; Latournerie M; Jooste V; Lepage C; Cottet V; Faivre J
Eur J Cancer; 2008 Mar; 44(4):522-7. PubMed ID: 18255278
[TBL] [Abstract][Full Text] [Related]
3. Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer.
Liu L; Lemmens VE; De Hingh IH; de Vries E; Roukema JA; van Leerdam ME; Coebergh JW; Soerjomataram I
Dis Colon Rectum; 2013 Feb; 56(2):158-68. PubMed ID: 23303143
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
5. Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.
Moon CM; Cheon JH; Choi EH; Kim ES; Park JJ; Han SY; Kim DH; Kim TI; Kim WH
J Clin Gastroenterol; 2010 Aug; 44(7):495-501. PubMed ID: 20351568
[TBL] [Abstract][Full Text] [Related]
6. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
7. Development of metachronous neoplasms after colorectal cancer resection: absence of synchronous neoplasms predicts a lower risk.
Rajaratnam SG; Dennett ER
N Z Med J; 2009 May; 122(1294):61-6. PubMed ID: 19465948
[TBL] [Abstract][Full Text] [Related]
8. Timing and detection of metachronous colorectal cancer.
Hollington P; Tiong L; Young G
ANZ J Surg; 2011 Apr; 81(4):272-4. PubMed ID: 21418472
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study.
Cottet V; Jooste V; Fournel I; Bouvier AM; Faivre J; Bonithon-Kopp C
Gut; 2012 Aug; 61(8):1180-6. PubMed ID: 22110052
[TBL] [Abstract][Full Text] [Related]
10. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
Gervaz P; Bucher P; Neyroud-Caspar I; Soravia C; Morel P
Dis Colon Rectum; 2005 Feb; 48(2):227-32. PubMed ID: 15711864
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
[TBL] [Abstract][Full Text] [Related]
12. Risk of bilateral renal cell cancer.
Wiklund F; Tretli S; Choueiri TK; Signoretti S; Fall K; Adami HO
J Clin Oncol; 2009 Aug; 27(23):3737-41. PubMed ID: 19597028
[TBL] [Abstract][Full Text] [Related]
13. Metachronous colorectal adenocarcinomas.
Tsantilas D; Ntinas A; Petras P; Zambas N; Al Mogrambi S; Frangandreas G; Spyridis C; Gerasimidis T
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s202-4. PubMed ID: 15655623
[TBL] [Abstract][Full Text] [Related]
14. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
15. Metachronous colorectal cancer.
Park IJ; Yu CS; Kim HC; Jung YH; Han KR; Kim JC
Colorectal Dis; 2006 May; 8(4):323-7. PubMed ID: 16630238
[TBL] [Abstract][Full Text] [Related]
16. [Do metachronous colorectal adenomas show proximal shift?].
Borda Martín A; Martínez-Peñuela JM; Muñoz-Navas M; Borda Celaya F; Jiménez Pérez J; Carretero Ribón C
Gastroenterol Hepatol; 2010; 33(6):419-24. PubMed ID: 20374971
[TBL] [Abstract][Full Text] [Related]
17. [Colorectal metachronous tumors].
Cerdán J; Torres-Melero J; Diez M; Balsa T; Balibrea JL
Rev Esp Enferm Dig; 1996 Oct; 88(10):655-9. PubMed ID: 8983303
[TBL] [Abstract][Full Text] [Related]
18. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
19. Metachronous colorectal cancer: a competing risks analysis with consideration for a stratified approach to surveillance colonoscopy.
Battersby NJ; Coupland A; Bouliotis G; Mirza N; Williams JG
J Surg Oncol; 2014 Apr; 109(5):445-50. PubMed ID: 24272767
[TBL] [Abstract][Full Text] [Related]
20. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
